
RCEL
Avita Medical Inc.
$5.92
+$0.45(+8.23%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$166.37M
Volume
281.35K
52W Range
$3.60 - $14.16
Target Price
$8.80
Order:
Income Statement
Metric | Trend | Chart | 2020 Jun | 2021 Jun | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|
REVENUE | |||||||
Total Revenue | $14.3M | $29.2M | $34.4M | $50.1M | $64.3M | ||
Total Revenue | $14.3M | $29.2M | $34.4M | $50.1M | $64.3M | ||
COST OF GOODS SOLD | |||||||
Cost of Revenue | $3.0M | $5.9M | $6.0M | $7.8M | $9.1M | ||
GROSS PROFIT | |||||||
Gross Profit | $11.3M | $23.3M | $28.4M | $42.4M | $55.2M | ||
OPERATING EXPENSES | |||||||
Operating Expenses | $57.9M | $51.9M | $55.9M | $86.4M | $111.8M | ||
Research & Development | $9.2M | $14.8M | $13.9M | $20.8M | $20.4M | ||
Research Expense | $9.2M | $14.8M | $13.9M | $20.8M | $20.4M | ||
Selling, General & Administrative | $48.7M | $37.1M | $45.2M | $65.6M | $91.4M | ||
Selling & Marketing Expenses | $15.7M | $14.7M | $21.9M | $37.3M | $58.2M | ||
General & Administrative Expenses | $33.0M | $22.4M | $23.3M | $28.3M | $33.2M | ||
Promotion & Advertising | $51.0K | $73.0K | $216.0K | -- | -- | ||
Salaries & Wages | $16.5M | $5.7M | $7.0M | -- | -- | ||
Depreciation & Amortization | $346.0K | $606.0K | $510.0K | $597.0K | $1.0M | ||
Depreciation & Amortization | $3.0M | $5.9M | $510.0K | -- | -- | ||
Amortization | $364.0K | $601.0K | $803.0K | $828.0K | $5.6M | ||
Other Operating Expenses | $-3.9M | $-2.1M | $-3.2M | $-1.4M | $111.8M | ||
OPERATING INCOME | |||||||
Operating income | $-42.7M | $-26.5M | $-27.5M | $-42.7M | $-56.6M | ||
EBITDA | $-41.5M | $-25.8M | $-26.0M | $-33.5M | $-55.3M | ||
NON-OPERATING ITEMS | |||||||
Interest Expense (Non-Operating) | $33.0K | $22.0K | $16.0K | $1.1M | $5.4M | ||
Net Non-Operating Interest Income/Expense | $-33.0K | $-22.0K | $-16.0K | $-1.1M | $-5.4M | ||
Other Income/Expense | $-686.0K | $-17.0K | $892.0K | $-8.5M | $-163.0K | ||
Other Special Charges | $686.0K | $17.0K | $892.0K | $8.5M | $163.0K | ||
SPECIAL ITEMS | |||||||
Special Income Charges | $3.9M | -- | -- | -- | -- | ||
PRE-TAX INCOME | |||||||
EBIT | $-42.0M | $-26.5M | $-26.6M | $-34.2M | $-56.4M | ||
Pre-Tax Income | $-42.0M | $-26.5M | $-26.6M | $-35.3M | $-61.8M | ||
INCOME TAX | |||||||
Tax Provision | $4.0K | $38.0K | $36.0K | $66.0K | $54.0K | ||
NET INCOME | |||||||
Net Income | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
Net Income (Continuing Operations) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
Net Income (Discontinued Operations) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
Net Income (Common Stockholders) | $-42.0M | $-26.6M | $-26.7M | $-35.4M | $-61.8M | ||
TOTALS | |||||||
Total Expenses | $60.9M | $57.8M | $61.9M | $94.2M | $120.8M | ||
SHARE & EPS DATA | |||||||
Average Shares Outstanding | $20.3M | $22.7M | $25.0M | $25.3M | $25.9M | ||
Average Shares Outstanding (Diluted) | $20.3M | $22.7M | $25.0M | $25.3M | $25.9M | ||
Shares Outstanding | $21.5M | $24.9M | $25.3M | $25.7M | $26.4M | ||
Basic EPS | $-2.07 | $-1.17 | $-1.07 | $-27.93 | $-2.39 | ||
Basic EPS (Continuing Operations) | $-2.07 | $-1.17 | $-1.07 | $-1.4 | $-2.39 | ||
Diluted EPS | $-2.07 | $-1.17 | $-1.07 | $-27.93 | $-2.39 | ||
Diluted EPS (Continuing Operations) | $-2.07 | $-1.17 | $-1.07 | $-1.4 | $-2.39 | ||
OTHER METRICS | |||||||
Acquisition Expense | -- | -- | $6.0M | -- | -- | ||
Depletion | $3.0M | $5.9M | -- | -- | -- | ||
Gain On Sale Of P P E | -- | -- | $-3.0K | -- | -- | ||
Other Gand A | $33.0M | $22.4M | $23.3M | $28.3M | $33.2M | ||
Other Write Off | $43.0K | -- | $9.0K | -- | -- | ||
Selling Expense | $3.0M | -- | $6.0M | -- | -- | ||
Othspecchg | $-3.9M | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | RCEL | $5.92 | +8.2% | 281.35K |
3 | ||||
4 | ||||
5 | ||||
6 |